2023 Partners
Precision For Medicine
Expertise Partner
Precision for Medicine is a next generation global CRO wired for CNS research. Our expertise spans neuropsychiatry, psychedelics, pain, insomnia and more. Unlock your development program’s potential with a truly end-to-end service offering—early- and late-phase Clinical Trials, Central and Specialty Labs, Data Sciences, Manufacturing, Biospecimens, and Commercialization. Precision integrates science, technology, data, and human expertise to propel theory to therapy and streamline time to patient impact.
Ulysses Neuroscience
Expertise Partner
Ulysses Neuroscience Ltd is a patient-centric private R&D organization working together with pharmaceutical companies in order to accelerate drug discovery in neuropsychiatric (major depression, anorexia nervosa and schizophrenia) and neurodevelopmental (Fragile X Syndrome and CDKL5 Deficiency Disorders) diseases by using translation clinical and pre-clinical research. Our translational research investigates neurophysiological and molecular mechanisms leading to the synaptic pathology, microtubule dynamics dysregulation and neuroinflammatory events.
Cellectricon
Innovation Partner
At Cellectricon, we create new avenues for neuroscience drug discovery. Our mission is to create groundbreaking concepts that will advance the neuroscience research field.
From early concept evaluation to transformative drug discovery campaigns, we solve your scientific challenges through innovative approaches for in vitro research.
- Obtain new insights into disease biology
- Accelerate the R&D process and reduce time-to-decision making
- Identify targets and lead compounds with potential to produce first-in-class medicines
Our unique discovery platform combines drug discovery expertise and disease area knowledge with cutting-edge technologies. With the platform, we are creating complex disease models and assays for functional and morphological screening.
Eurofins BioPharma Product Testing
Innovation Partner
Eurofins BioPharma Product Testing (BPT) delivers a broad range of harmonized methodologies under GMP authorization and certification. We offer R&D services for method development of analytical methods suitable for GMP Chemistry and Microbiology testing and certification of raw materials and finished products. Our 30,000 ft2 laboratory is equipped with state of the art analytical instrumentation and includes a sterility suite, a wide array of stability chambers as well as an extensive controlled drug substance license, and narcotics vault.
PsychoGenics
Innovation Partner
PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best-validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments and reduce the attrition rate in clinical development. Our capabilities include behavioral testing, surgical models, electrophysiology, translational EEG, quantitative histology, biomarker analysis, bioanalysis, and microdialysis. We offer a variety of validated mouse models, including in-licensed transgenic models that support research in areas such as amyotrophic lateral sclerosis, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.
Sama Therapeutics
Innovation Partner
Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company's agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing "software as medical device" for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms:
Biotrial
Exhibition Partner
Biotrial is a leading CRO specialized in Drug Development with a wide range of expertise in: Non-Clinical Pharmacology, Clinical Development (Phase I studies with HV & special populations in our 2 CPUs in the US and Europe) Bioanalysis, Biometrics, ECG, CNS & Imaging. Biotrial has experience in all phases of preclinical and clinical development with specific expertise in the CNS field. We offer specialized techniques and assessments for psychiatric and neurological studies such as CNS pharmacodynamics, EEG, ERPs, PSG, and sleep studies. Biotrial’s Core lab offers clinical site support and equipment worldwide with state-of-the-art equipment available and experienced experts for site training.
Feel Therapeutics
Event Partner
Feel Therapeutics, Inc. is bringing objective data and measurement into the way we diagnose, manage, and care for mental disorders, to realize the vision of Digital Precision Medicine for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and has partnerships with large pharmaceutical companies to develop novel digital biomarkers and bring digital health solutions to market as standalone digital treatment (DTx) or alongside medications. Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe.
